Consistent with our finding, Vermeulen and colleagues reported that multiple glycolytic enzymes, including aldolase A, phosphoglycerate mutase, alpha-enolase, triosephosphate isomerase, and malate dehydrogenase, showed strong seroreactivity in IBD patients using the immunoproteomic approach. Here, ENO1 is linked to inflammatory bowel disease.